Literature DB >> 26826186

SHIP2 controls plasma membrane PI(4,5)P2 thereby participating in the control of cell migration in 1321 N1 glioblastoma cells.

William's Elong Edimo1, Somadri Ghosh1, Rita Derua2, Veerle Janssens2, Etienne Waelkens2, Jean-Marie Vanderwinden3, Pierre Robe4, Christophe Erneux5.   

Abstract

Phosphoinositides, particularly phosphatidylinositol (3,4,5)-trisphosphate [PI(3,4,5)P3] and phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2], are recognized by SHIP2 (also known as INPPL1) a member of the inositol polyphosphate 5-phosphatase family. SHIP2 dephosphorylates PI(3,4,5)P3 to form PI(3,4)P2; the latter interacts with specific target proteins (e.g. lamellipodin). Although the preferred SHIP2 substrate is PI(3,4,5)P3, PI(4,5)P2 can also be dephosphorylated by this enzyme to phosphatidylinositol 4-phosphate (PI4P). Through depletion of SHIP2 in the glioblastoma cell line 1321 N1, we show that SHIP2 inhibits cell migration. In different glioblastoma cell lines and primary cultures, SHIP2 staining at the plasma membrane partly overlaps with PI(4,5)P2 immunoreactivity. PI(4,5)P2 was upregulated in SHIP2-deficient N1 cells as compared to control cells; in contrast, PI4P was very much decreased in SHIP2-deficient cells. Therefore, SHIP2 controls both PI(3,4,5)P3 and PI(4,5)P2 levels in intact cells. In 1321 N1 cells, the PI(4,5)P2-binding protein myosin-1c was identified as a new interactor of SHIP2. Regulation of PI(4,5)P2 and PI4P content by SHIP2 controls 1321 N1 cell migration through the organization of focal adhesions. Thus, our results reveal a new role of SHIP2 in the control of PI(4,5)P2, PI4P and cell migration in PTEN-deficient glioblastoma 1321 N1 cells.
© 2016. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Cell migration; Focal adhesion; Phosphoinositide; SHIP2

Mesh:

Substances:

Year:  2016        PMID: 26826186     DOI: 10.1242/jcs.179663

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  18 in total

Review 1.  The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease.

Authors:  Ana Raquel Ramos; Somadri Ghosh; Christophe Erneux
Journal:  J Lipid Res       Date:  2018-09-07       Impact factor: 5.922

2.  Epidermal Growth Factor Receptor and Abl2 Kinase Regulate Distinct Steps of Human Papillomavirus 16 Endocytosis.

Authors:  Carina Bannach; Pia Brinkert; Lena Kühling; Lilo Greune; M Alexander Schmidt; Mario Schelhaas
Journal:  J Virol       Date:  2020-05-18       Impact factor: 5.103

3.  Structural basis for interdomain communication in SHIP2 providing high phosphatase activity.

Authors:  Johanne Le Coq; Marta Camacho-Artacho; José Vicente Velázquez; Clara M Santiveri; Luis Heredia Gallego; Ramón Campos-Olivas; Nicole Dölker; Daniel Lietha
Journal:  Elife       Date:  2017-08-09       Impact factor: 8.140

4.  PI(3,4)P2 plays critical roles in the regulation of focal adhesion dynamics of MDA-MB-231 breast cancer cells.

Authors:  Miki Fukumoto; Takeshi Ijuin; Tadaomi Takenawa
Journal:  Cancer Sci       Date:  2017-05-11       Impact factor: 6.716

5.  Underexpression of INPPL1 is associated with aggressive clinicopathologic characteristics in papillary thyroid carcinoma.

Authors:  Yi-Li Zhou; Chen Zheng; Yi-Tong Chen; Xue-Min Chen
Journal:  Onco Targets Ther       Date:  2018-11-01       Impact factor: 4.147

6.  Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity.

Authors:  Zydrune Polianskyte-Prause; Tuomas A Tolvanen; Sonja Lindfors; Vincent Dumont; Mervi Van; Hong Wang; Surjya N Dash; Mika Berg; Jette-Britt Naams; Laura C Hautala; Harry Nisen; Tuomas Mirtti; Per-Henrik Groop; Kristiina Wähälä; Jukka Tienari; Sanna Lehtonen
Journal:  FASEB J       Date:  2018-10-15       Impact factor: 5.834

7.  The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer.

Authors:  Ruobing Wang; Yan Jiao; Yanqing Li; Siyang Ye; Guoqiang Pan; Shanshan Qin; Fang Hua; Yahui Liu
Journal:  Biomed Res Int       Date:  2020-04-25       Impact factor: 3.411

Review 8.  Targeting SHIP1 and SHIP2 in Cancer.

Authors:  Chiara Pedicone; Shea T Meyer; John D Chisholm; William G Kerr
Journal:  Cancers (Basel)       Date:  2021-02-20       Impact factor: 6.639

9.  Inositol-requiring enzyme-1 regulates phosphoinositide signaling lipids and macrophage growth.

Authors:  Syed Muhammad Hamid; Mevlut Citir; Erdem Murat Terzi; Ismail Cimen; Zehra Yildirim; Asli Ekin Dogan; Begum Kocaturk; Umut Inci Onat; Moshe Arditi; Christian Weber; Alexis Traynor-Kaplan; Carsten Schultz; Ebru Erbay
Journal:  EMBO Rep       Date:  2020-11-02       Impact factor: 9.071

Review 10.  PI(3,4)P2 Signaling in Cancer and Metabolism.

Authors:  Luca Gozzelino; Maria Chiara De Santis; Federico Gulluni; Emilio Hirsch; Miriam Martini
Journal:  Front Oncol       Date:  2020-03-31       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.